These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 8352710)

  • 21. Transfusion-associated graft-versus-host disease: risk due to homozygous HLA haplotypes.
    Wagner FF; Flegel WA
    Transfusion; 1995 Apr; 35(4):284-91. PubMed ID: 7701545
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Risk of transfusion-associated graft-versus-host disease as a result of directed donations from relatives.
    Ohto H; Yasuda H; Noguchi M; Abe R
    Transfusion; 1992 Sep; 32(7):691-3. PubMed ID: 1519336
    [No Abstract]   [Full Text] [Related]  

  • 23. Transfusion-associated graft-versus-host disease: scratching the surface.
    Shivdasani RA; Anderson KC
    Transfusion; 1993 Sep; 33(9):696-7. PubMed ID: 8212111
    [No Abstract]   [Full Text] [Related]  

  • 24. Transfusion associated graft versus host disease in an immunocompetent patient.
    O'Connor NT; Mackintosh P
    J Clin Pathol; 1992 Jul; 45(7):621-2. PubMed ID: 1517464
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Fatal erythroderma (suspected graft-versus-host disease) after cholecystectomy. Retrospective analysis.
    Otsuka S; Kunieda K; Hirose M; Takeuchi H; Mizutani Y; Nagaya M; Sato G; Kasuya S; Matsutomo K; Noma A
    Transfusion; 1989; 29(6):544-8. PubMed ID: 2526400
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The role of blood from HLA-homozygous donors in fatal transfusion-associated graft-versus-host disease after open-heart surgery.
    Thaler M; Shamiss A; Orgad S; Huszar M; Nussinovitch N; Meisel S; Gazit E; Lavee J; Smolinsky A
    N Engl J Med; 1989 Jul; 321(1):25-8. PubMed ID: 2786605
    [No Abstract]   [Full Text] [Related]  

  • 27. Graft versus host disease following transfusion of normal blood products to patients with malignancies.
    Kessinger A; Armitage JO; Klassen LW; Landmark JD; Hayes JM; Larsen AE; Purtilo DT
    J Surg Oncol; 1987 Nov; 36(3):206-9. PubMed ID: 3316850
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Fatal transfusion-associated graft-versus-host disease in an immunocompetent recipient of a volunteer unit of red cells.
    Triulzi D; Duquesnoy R; Nichols L; Clark K; Jukic D; Zeevi A; Meisner D
    Transfusion; 2006 Jun; 46(6):885-8. PubMed ID: 16734803
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Transfusion-associated graft-versus-host disease in nonimmunocompromised hosts.
    Vogelsang GB
    Transfusion; 1990 Feb; 30(2):101-3. PubMed ID: 2137651
    [No Abstract]   [Full Text] [Related]  

  • 30. Successful treatment of transfusion-associated graft-versus-host disease.
    Yasukawa M; Shinozaki F; Hato T; Takada K; Ishii Y; Tamai T; Takamatsu H; Shiobara S; Yoshizaki K; Fujita S
    Br J Haematol; 1994 Apr; 86(4):831-6. PubMed ID: 7918080
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Transfusion associated graft versus host disease in an immunocompetent individual following coronary artery bypass grafting.
    Ahya R; Douglas JG; Watson HG
    Heart; 1998 Sep; 80(3):299-300. PubMed ID: 9875094
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cellular kinetics of posttransfusion graft-versus-host disease after heart operations.
    Mayumi H; Matsui K; Matsuzaki K; Uchida T; Shinozaki K; Tokunaga K
    J Thorac Cardiovasc Surg; 1994 Jul; 108(1):179-82. PubMed ID: 8028366
    [No Abstract]   [Full Text] [Related]  

  • 33. [Successful unrelated HLA-mis matched cord blood transplantation in pediatric patients with severe aplastic anemia].
    Zhu XH; Zhang YL; Wei XD
    Zhonghua Er Ke Za Zhi; 2006 Feb; 44(2):143-4. PubMed ID: 16624036
    [No Abstract]   [Full Text] [Related]  

  • 34. Hyperacute graft-vs.-host disease after related HLA-identical umbilical cord blood transplantation.
    Kuskonmaz B; Gocer S; Ersoy-Ewans S; Cetin Ozman F; Cetin M; Uckan D
    Pediatr Transplant; 2007 Nov; 11(7):818-20. PubMed ID: 17910666
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Fatal graft-versus-host disease following transfusion of granulocytes from normal donors.
    Ford JM; Cullen MH; Lucey JJ; Tobias JS; Lister TA
    Lancet; 1976 Nov; 2(7996):1167-9. PubMed ID: 62996
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A rapid molecular diagnosis of posttransfusion graft-versus-host disease by polymerase chain reaction.
    Hayakawa S; Chishima F; Sakata H; Fujii K; Ohtani K; Kurashina K; Hayakawa J; Suzuki K; Nakabayashi H; Esumi M
    Transfusion; 1993 May; 33(5):413-7. PubMed ID: 8488546
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Mixed epidermal cell-lymphocyte reaction in prediction of acute graft-versus-host disease in bone marrow recipients.
    Bagot M; Cordonnier C; Vernant JP; Dubertret L; Rochant H; Levy JP
    J Natl Cancer Inst; 1986 Jun; 76(6):1317-9. PubMed ID: 3520075
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Post-transfusion graft-versus-host disease].
    Takahashi K
    Rinsho Ketsueki; 1992 May; 33(5):582-6. PubMed ID: 1630009
    [No Abstract]   [Full Text] [Related]  

  • 39. [HLA typing in a neonate with posttransfusional graft vs host disease (PT-GVHD)].
    Lista GL; Porcelli F; Mercuriali F; Farè M; Taccone F
    Pediatr Med Chir; 1994; 16(3):285-7. PubMed ID: 7971455
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Predictors of acute graft-versus-host disease in bone marrow transplantation between HLA-identical siblings.
    Johnsen HE
    N Engl J Med; 1993 May; 328(20):1497-8. PubMed ID: 8479479
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.